Our Research Publications
Updated November 2023
Pagination
- Previous page
- Page 41
- Next page
Title | Authors | Year Sort ascending | Journal | Link to Article | Intended Audience | Purpose |
---|---|---|---|---|---|---|
Evaluating the 4-hour and 30-minute rules: effects of room temperature exposure on red blood cell quality and bacterial growth | Ramirez-Arcos S, Mastronardi C, Perkins H, Kou Y, Turner T, Mastronardi E, Hansen A, Yi QL, McLaughlin N, Kahwash E, Lin Y, Acker J | 2013 | Transfusion | View Evaluating the 4-hour and 30-minute rules: effects of room temperature exposure on red blood cell quality and bacterial growth | Regulators | New or improved product or process |
FcgRIIa proteolysis as a diagnostic biomarker for heparin-induced thrombocytopenia | Nazi I, Arnold DM, Smith JW, Horsewood P, Moore JC, Warkentin TE, Crowther MA, Kelton JG | 2013 | J Thromb Haemost | View FcgRIIa proteolysis as a diagnostic biomarker for heparin-induced thrombocytopenia | Researchers | Basic research |
Co-stimulation with LPS or Poly I:C markedly enhances the anti-platelet immune response and severity of fetal and neonatal alloimmune thrombocytopenia | Li C, Chen P, Vadasz B, Ma L, Zhou H, Lang S, Freedman J, Ni H | 2013 | Thromb Haemost | View Co-stimulation with LPS or Poly I:C markedly enhances the anti-platelet immune response and severity of fetal and neonatal alloimmune thrombocytopenia | Researchers | Basic research |
Quality of red blood cells washed using the ACP 215 cell processor: assessment of optimal pre- and postwash storage times and conditions | Hansen A, Yi QL, Acker JP | 2013 | Transfusion | View Quality of red blood cells washed using the ACP 215 cell processor: assessment of optimal pre- and postwash storage times and conditions | Researchers | New or improved product or process |
Adjudication of bleeding outcomes in an international thromboprophylaxis trial in critical illness | Arnold DM, Lauzier F, Rabbat C, Zytaruk N, Barlow Cash B, Clarke F, Heels-Ansdell D, Guyatt G, Walter SD, Davies A, Cook DJ, PROTECT Investigators on behalf of the Canadian Critical Care Trials Group and the Australian and New Zealand Intensive Care Clinical Trials Group | 2013 | Thromb Res | View Adjudication of bleeding outcomes in an international thromboprophylaxis trial in critical illness | Researchers | Clinical research |
Challenges in the management of the blood supply | Williamson LM, Devine DV | 2013 | Lancet | View Challenges in the management of the blood supply | Blood operators | Other |
Fusion of the C-terminal triskaidecapeptide of hirudin variant 3 to alpha1-proteinase inhibitor M358R increases the serpin-mediated rate of thrombin inhibition | Roddick LA, Bhakta V, Sheffield W | 2013 | BMC Biochem | View Fusion of the C-terminal triskaidecapeptide of hirudin variant 3 to alpha1-proteinase inhibitor M358R increases the serpin-mediated rate of thrombin inhibition | Researchers | Basic research |
Legal Aspects of the Blood System in Canada | Reis NM | 2013 | Public Health Law and Policy in Canada | View Legal Aspects of the Blood System in Canada | Other | Other |
A case of vertical transmission of Chagas Disease contracted via blood transfusion in Canada | Fearon MA, Scalia V, Huang M, Dines I, Ndao M | 2013 | Can J Infect Dis Med Microbiol | View A case of vertical transmission of Chagas Disease contracted via blood transfusion in Canada | Health care providers | Clinical research |
Positioning new treatments in the management of immune thrombocytopenia | Arnold DM | 2013 | Pediatr Blood Cancer | View Positioning new treatments in the management of immune thrombocytopenia | Researchers | Clinical research |
Amelioration of Murine Passive Immune Thrombocytopenia by IVIg and a Therapeutic Monoclonal CD44 Antibody Does Not Require the Myd88 Signaling Pathway | Crow AR, Yu H, Han D, Lazarus AH | 2013 | PLoS One | View Amelioration of Murine Passive Immune Thrombocytopenia by IVIg and a Therapeutic Monoclonal CD44 Antibody Does Not Require the Myd88 Signaling Pathway | Researchers | Basic research |
Donor hemovigilance | Goldman M | 2013 | Blood Transfus | View Donor hemovigilance | Health care providers | Other |
Expert approaches to common bleeding and thrombotic problems, part II | Hayward CP, Webert KE | 2013 | Semin Thromb Hemost | View Expert approaches to common bleeding and thrombotic problems, part II | Health care providers | Other |
Research with Blood Donated to Blood Banking Organizations | Reis NM | 2013 | Health Law Review | View Research with Blood Donated to Blood Banking Organizations | Other | Other |
Utility of cross-matched platelet transfusions in patients with hypoproliferative thrombocytopenia: a systematic review | Vassallo RR, Fung M, Rebulla P, Duquesnoy R, Saw CL, Slichter SJ, Tanael S, Shehata N, International Collaboration for Guideline Development Implementation Evaluation for Transfusion Therapies Collaborators | 2013 | Transfusion | View Utility of cross-matched platelet transfusions in patients with hypoproliferative thrombocytopenia: a systematic review | Researchers | Clinical research |
A platelet cover-up | Arnold DM | 2013 | Blood | View A platelet cover-up | Researchers | Other |
Legal Foundations of Public Health Law | Reis NM | 2013 | Public Health Law and Policy in Canada | View Legal Foundations of Public Health Law | Other | Other |
Phospholipidomics reveals differences in glycerophosphoserine profiles of hypothermically stored red blood cells and microvesicles | Bicalho B, Holovati JL, Acker JP | 2013 | Biochim Biophys Acta | View Phospholipidomics reveals differences in glycerophosphoserine profiles of hypothermically stored red blood cells and microvesicles | Researchers | Basic research |
The complete N-terminal extension of heparin cofactor II is required for maximal effectiveness as a thrombin exosite 1 ligand | Boyle AJ, Roddick LA, Bhakta V, Lambourne MD, Junop MS, Liaw PC, Weitz JI, Sheffield WP | 2013 | BMC Biochem | View The complete N-terminal extension of heparin cofactor II is required for maximal effectiveness as a thrombin exosite 1 ligand | Researchers | Basic research |
Reduction of thrombus size in murine models of thrombosis following administration of recombinant alpha1-proteinase inhibitor mutant proteins | Sheffield WP, Eltringham-Smith LJ, Bhakta V, Gataiance S | 2012 | Thromb Haemost | View Reduction of thrombus size in murine models of thrombosis following administration of recombinant alpha1-proteinase inhibitor mutant proteins | Researchers | Basic research |
SHP-1 protein tyrosine phosphatase associates with the adaptor protein CrkL | Evren S, Ma XZ, Sakac D, Branch DR | 2012 | Exp Hematol | View SHP-1 protein tyrosine phosphatase associates with the adaptor protein CrkL | Researchers | Basic research |
Toward a prophylaxis against fetal and neonatal alloimmune thrombocytopenia: induction of antibody-mediated immune suppression and prevention of severe clinical complications in a murine model | Tiller H, Killie MK, Chen P, Eksteen M, Husebekk A, Skogen B, Kjeldsen-Kragh J, Ni H | 2012 | Transfusion | View Toward a prophylaxis against fetal and neonatal alloimmune thrombocytopenia: induction of antibody-mediated immune suppression and prevention of severe clinical complications in a murine model | Researchers | Basic research |
An analysis of the bias in red blood cell hemolysis measurement using several analytical approaches | Acker JP, Croteau IM, Yi QL | 2012 | Clin Chim Acta | View An analysis of the bias in red blood cell hemolysis measurement using several analytical approaches | Researchers | New or improved product or process |
Expert approaches to common bleeding and thrombotic problems-part I | Hayward CP, Webert KE | 2012 | Semin Thromb Hemost | View Expert approaches to common bleeding and thrombotic problems-part I | Health care providers | Other |
Influence of polymer architecture on antigens camouflage, CD47 protection and complement mediated lysis of surface grafted red blood cells | Chapanian R, Constantinescu I, Rossi NA, Medvedev N, Brooks DE, Scott MD, Kizhakkedathu JN | 2012 | Biomaterials | View Influence of polymer architecture on antigens camouflage, CD47 protection and complement mediated lysis of surface grafted red blood cells | Researchers | Basic research |
The impact of increasing the upper age limit of donation on the eligible blood donor population in Canada | Fan W, Yi QL, Xi G, Goldman M, Germain M, O'Brien SF | 2012 | Transfus Med | View The impact of increasing the upper age limit of donation on the eligible blood donor population in Canada | Blood operators | New or improved product or process |
A prospective study measuring the development of antibodies against platelet factor 4-heparin in healthy males after exposure to heparins | Kelton JG, Warkentin TE, Moore JC, Arnold DM, Nazi I, Arepally GM, Roach JM, Fier I | 2012 | J Thromb Haemost | View A prospective study measuring the development of antibodies against platelet factor 4-heparin in healthy males after exposure to heparins | Health care providers | Clinical research |
Changes in coagulation factor activity and content of di(2-ethylhexyl)phthalate in frozen plasma units during refrigerated storage for up to five days after thawing | Sheffield WP, Bhakta V, Mastronardi C, Ramirez-Arcos S, Howe D, Jenkins C | 2012 | Transfusion | View Changes in coagulation factor activity and content of di(2-ethylhexyl)phthalate in frozen plasma units during refrigerated storage for up to five days after thawing | Health care providers | New or improved product or process |
Impact of Pandemic Influenza A (H1N1) on Laboratory Services | Patel SN, Gubbay JB, Bastien N, Booth T, Charest H, Chernesky M, Couillard M, Drews S, Garceau R, Gubbay J, Guercio S, Fearon M, Fonseca K, Hatchette T, Horsman G, Larke B, Li Y, Majury A, Ouellette O, Petric M, Ratnam S, Sevenhuysen C, Van Caeseele P | 2012 | National Collaborating Centre for Infectious Diseases: Evidence Reviews on Pandemic H1N1 | View Impact of Pandemic Influenza A (H1N1) on Laboratory Services | Health care providers | Other |
Selective testing for Trypanosoma cruzi: the first year after implementation at Canadian Blood Services | O'Brien SF, Scalia V, Goldman M, Fan W, Yi QL, Dines IR, Huang M, Ndao M, Fearon MA | 2012 | Transfusion | View Selective testing for Trypanosoma cruzi: the first year after implementation at Canadian Blood Services | Blood operators | New or improved product or process |
Low-intensity pulsed ultrasound-mediated stimulation of hematopoietic stem/progenitor cell viability, proliferation and differentiation in vitro | Xu P, Gul-Uludag H, Ang WT, Yang X, Huang M, Marquez-Curtis L, McGann L, Janowska-Wieczorek A, Xing J, Swanson E, Chen J | 2012 | Biotechnol Lett | View Low-intensity pulsed ultrasound-mediated stimulation of hematopoietic stem/progenitor cell viability, proliferation and differentiation in vitro | Researchers | Basic research |
Platelet antibodies and fetal growth: maternal antibodies against fetal platelet antigen 1a are strongly associated with reduced birthweight in boys | Tiller H, Killie MK, Husebekk A, Skogen B, Ni H, Kjeldsen-Kragh J, Olan P | 2012 | Acta Obstet Gyn Scan | View Platelet antibodies and fetal growth: maternal antibodies against fetal platelet antigen 1a are strongly associated with reduced birthweight in boys | Health care providers | Clinical research |
Riboflavin and ultraviolet light treatment potentiates vasodilator-stimulated phosphoprotein Ser-239 phosphorylation in platelet concentrates during storage | Schubert P, Culibrk B, Coupland D, Scammell K, Gyongyossy-Issa M, Devine DV | 2012 | Transfusion | View Riboflavin and ultraviolet light treatment potentiates vasodilator-stimulated phosphoprotein Ser-239 phosphorylation in platelet concentrates during storage | Researchers | Basic research |
Donor motivation in Xi'an, China: comparison with Canadian donors | O'Brien SF, Shao ZJ, Osmond L, Yi QL, Li CY, An QX | 2012 | Vox Sang | View Donor motivation in Xi'an, China: comparison with Canadian donors | Blood operators | Other |
Herpesviruses enhance fibrin clot lysis | Gershom ES, Vanden Hoek AL, Meixner SC, Sutherland MR, Pryzdial EL | 2012 | Thromb Haemost | View Herpesviruses enhance fibrin clot lysis | Researchers | Basic research |
Kruppel-like factor 1 (KLF1), KLF2, and Myc control a regulatory network essential for embryonic erythropoiesis | Pang CJ, Lemsaddek W, Alhashem YN, Bondzi C, Redmond LC, Ah-Son N, Dumur CI, Archer KJ, Haar JL, Lloyd JA, Trudel M | 2012 | Mol Cell Biol | View Kruppel-like factor 1 (KLF1), KLF2, and Myc control a regulatory network essential for embryonic erythropoiesis | Researchers | Basic research |
Measures to prevent transfusion-related acute lung injury (TRALI) | Reesink HW, Lee J, Keller A, Dennington P, Pink J, Holdsworth R, Schennach H, Goldman M, Petraszko T, Sun J, Meng Y, Qian K, Rehacek V, Turek P, Krusius T, Juvonen E, Tiberghien P, Legrand D, Semana G, Muller JY, Bux J, Reil A, Lin CK, Daly H, McSweeney E, Porretti L, Greppi N, Rebulla P, Okazaki H, Sanchez-Guerrero SA, Baptista-Gonzalez HA, Martinez-Murillo C, Guerra-Marquez A, Rodriguez-Moyado H, Middelburg RA, Wiersum-Osselton JC, Brand A, van Tilburg C, Dinesh D, Dagger J, Dunn P, Brojer E, Letowska M, Maslanka K, Lachert E, Uhrynowska M, Zhiburt E, Palfi M, Berlin G, Frey BM, Puig Rovira L, Muniz-Diaz E, Castro E, Chapman C, Green A, Massey E, Win N, Williamson L, Silliman CC, Chaffin DJ, Ambruso DR, Blumberg N, Tomasulo P, Land KJ, Norris PJ, Illoh OC, Davey RJ, Benjamin RJ, Eder AF, McLaughlin L, Kleinman S, Panzer S | 2012 | Vox Sang | View Measures to prevent transfusion-related acute lung injury (TRALI) | Blood operators | Benchmarking and standard setting |
Lessons learned from Trypanosoma cruzi test implementation | Menitove JE, Leach-Bennett J, Sher G | 2012 | Transfusion | View Lessons learned from Trypanosoma cruzi test implementation | Blood operators | Other |
Mouse background and IVIG dosage are critical in establishing the role of inhibitory Fcgamma receptor for the amelioration of experimental ITP | Leontyev D, Katsman Y, Branch DR | 2012 | Blood | View Mouse background and IVIG dosage are critical in establishing the role of inhibitory Fcgamma receptor for the amelioration of experimental ITP | Researchers | Basic research |
Optimization of platelet concentrate quality: Application of proteomic technologies to donor management | Schubert P, Culibrk B, Karwal S, Slichter SJ, Devine DV | 2012 | J Proteomics | View Optimization of platelet concentrate quality: Application of proteomic technologies to donor management | Blood operators | Basic research |
Platelets in Thrombosis and Hemostasis: Old Topic with New Mechanisms | Wang Y, Andrews M, Yang Y, Lang S, Jin JW, Cameron-Vendrig A, Zhu G, Reheman A, Ni H | 2012 | Cardiovasc Hematol Disord Drug Targets | View Platelets in Thrombosis and Hemostasis: Old Topic with New Mechanisms | Health care providers | Basic research |
A flow cytometric method for platelet counting in platelet concentrates | van der Meer PF, Karssing-van Leeuwen W, Kurtz J, Spengler H-P, Blair A, Devine D, Harrison P, Lambrecht B, VandenBroeke T, de Wildt J, de Korte D, on behalf of the Biomedical Excellence for Safer Transfusion C | 2012 | Transfusion | View A flow cytometric method for platelet counting in platelet concentrates | Researchers | New or improved product or process |
Hematopoietic Stem Cell Mobilization and Homing after Transplantation: The Role of MMP-2, MMP-9, and MT1-MMP | Shirvaikar N, Marquez-Curtis LA, Janowska-Wieczorek A | 2012 | Biochem Res Int | View Hematopoietic Stem Cell Mobilization and Homing after Transplantation: The Role of MMP-2, MMP-9, and MT1-MMP | Researchers | Basic research |
Sialylation-independent mechanism involved in the amelioration of murine immune thrombocytopenia using intravenous gammaglobulin | Leontyev D, Katsman Y, Ma XZ, Miescher S, Kasermann F, Branch DR | 2012 | Transfusion | View Sialylation-independent mechanism involved in the amelioration of murine immune thrombocytopenia using intravenous gammaglobulin | Researchers | Basic research |
Towards a prophylactic treatment of HPA-related foetal and neonatal alloimmune thrombocytopenia | Kjeldsen-Kragh J, Ni H, Skogen B | 2012 | Curr Opin Hematol | View Towards a prophylactic treatment of HPA-related foetal and neonatal alloimmune thrombocytopenia | Researchers | Other |
Crosstalk between Platelets and the Immune System: Old Systems with New Discoveries | Li C, Li J, Li Y, Lang S, Yougbare I, Zhu G, Chen P, Ni H | 2012 | Adv Hematol | View Crosstalk between Platelets and the Immune System: Old Systems with New Discoveries | Researchers | Basic research |
Impact de la grippe pandémique A (H1N1) sur les services de laboratoire | Patel SN, Gubbay JB, Bastien N, Booth T, Charest H, Chernesky M, Couillard M, Drews S, Garceau R, Gubbay J, Guercio S, Fearon M, Fonseca K, Hatchette T, Horsman G, Larke B, Li Y, Majury A, Ouellette O, Petric M, Ratnam S, Sevenhuysen C, Van Caeseele P | 2012 | Centre de collaboration nationale des maladies infectieuses: Examen des Preuves La grippe pandemique A (H1N1) | View Impact de la grippe pandémique A (H1N1) sur les services de laboratoire | Health care providers | Other |
Modulation of microRNA Activity by Semi-microRNAs | Plante I, Ple H, Landry P, Gunaratne PH, Provost P | 2012 | Front Genet | View Modulation of microRNA Activity by Semi-microRNAs | Researchers | Basic research |
Rituximab maintenance for relapsed refractory thrombotic thrombocytopenic purpura | Bhagirath VC, Kelton JG, Moore J, Arnold DM | 2012 | Transfusion | View Rituximab maintenance for relapsed refractory thrombotic thrombocytopenic purpura | Health care providers | Clinical research |
Validation and implementation of a new hemoglobinometer for donor screening at Canadian Blood Services | Goldman M, Uzicanin S, Yi QL, Acker JP, Ramirez-Arcos S | 2012 | Transfusion | View Validation and implementation of a new hemoglobinometer for donor screening at Canadian Blood Services | Blood operators | New or improved product or process |